Recurrence in Node-Positive Breast Cancer Treated With Tamoxifen

[tousled1]

SAN ANTONIO, TX -- December 14, 2007 -- A 21-gene prognostic assay (Oncotype DX) predicts disease recurrence in patients with node-positive breast cancer who are treated with tamoxifen, according to a randomized trial.

Read entire article:

http://www.docguide.com/news/content.nsf/news/852571020057CCF6852573B10059B6D2